Okada, Yusuke

写真a

Affiliation

Faculty of Pharmacy, Department of Pharmacy Division of Drug Development and Regulatory Science (Shiba-Kyoritsu)

Position

Research Associate/Assistant Professor/Instructor

Academic Background 【 Display / hide

  • 2008.04
    -
    2014.03

    Nagoya City University, Faculty of Pharmaceutical Sciences

    University, Graduated

  • 2019.04
    -
    2023.03

    Meiji Pharmaceutical University

    Graduate School, Completed, Doctoral course

Academic Degrees 【 Display / hide

  • Ph.D., Meiji Pharmaceutical University, Coursework, 2023.03

 

Papers 【 Display / hide

  • Risk of Thrombocytopenia by SSRIs or SNRIs in Patients With Depression Based on MID-NET: A Cohort Study in Japan

    Y Okada, K Kajiyama, M Komamine, T Ando, T Hasegawa, C Ishiguro, ...

    Clinical and Translational Science 18 (6), e70268 18 ( 6 ) e70268 2025.06

    ISSN  1752-8054

  • New Function for Safety Signal Monitoring in MID-NET(®): The Case of an Anti-COVID-19 Drug.

    Okada Y, Ando T, Takahashi F, Watanabe K, Kajiyama K, Hasegawa T, Inomata S, Kinoshita Y, Watanabe S, Uyama Y

    Clinical and translational science 18 ( 4 ) e70208 2025.04

    ISSN  1752-8054

  • Risk of neutropenia in psoriasis patients prescribed anti-IL-23 antibody in comparison with anti-IL-17 antibody or adalimumab based on real-world data from the MID-NET(®) in Japan.

    Okada Y, Kajiyama K, Ishiguro C, Nonaka T, Komaki T, Kuga W, Komiyama N, Iguchi T, Horiuchi N, Uyama Y

    The Journal of dermatological treatment 35 ( 1 ) 2373826 2024.12

    Research paper (scientific journal), Lead author, Accepted,  ISSN  0954-6634

  • Comparative Effectiveness of Long-Acting Injectable Versus Oral Antipsychotics in Patients With Schizophrenia Using the Prevalent New User Design and Subgroup Analyses

    Y Okada, K Inada, M Akazawa

    Journal of Clinical Psychopharmacology 44 (3), 263-271 44 ( 3 ) 263 - 271 2024.05

    Research paper (scientific journal), Lead author, Accepted,  ISSN  0271-0749

  • Prescription trend and lactic acidosis in patients prescribed metformin before and after the revision of package insert for allowing metformin administration to patients with …

    T Waki, Y Okada, Y Kinoshita, K Kajiyama, C Ishiguro, Y Nakazato, ...

    Frontiers in Medicine 10, 1294696  2024

    Research paper (scientific journal), Accepted

display all >>

Reviews, Commentaries, etc. 【 Display / hide

  • 【MID-NET運用開始5周年を迎えて】MID-NETのこれまでと今後 大切にしてきたこと

    關野 一石, 中野 千佳子, 村山 一茂, 高橋 史峰, 飛知和 康史, 原田 紗世子, 大田 有佳里, 岸塲 真理, 堀木 稚子, 梶山 和浩, 岡田 佑輔, 山口 光峰, 宇山 佳明

    レギュラトリーサイエンス学会誌 ((一社)レギュラトリーサイエンス学会)  14 ( 1 ) 107 - 122 2024.01

    ISSN  2185-7113

     View Summary

    MID-NETは,2018年4月1日から本格運用を開始し,2023年4月をもち運用開始5周年を迎えた.MID-NETの概要とこれまでの取り組みについて述べるともに,MID-NET運営を行う上で大切にしてきたこと,アウトカムバリデーションの取り組み,独立行政法人医薬品医療機器総合機構(PMDA)がMID-NETを活用した事例について紹介したい.(著者抄録)

  • 今月のTopic 市販後安全対策 MID-NETを活用した早期安全性シグナルモニタリングについて

    岡田 佑輔, 野中 孝浩, 宇山 佳明

    医薬品医療機器レギュラトリーサイエンス ((一財)医薬品医療機器レギュラトリーサイエンス財団)  52 ( 8 ) 646 - 648 2021.12

    ISSN  1884-6076

 

Courses Taught 【 Display / hide

  • STUDY OF MAJOR FIELD: (DRUG DEVELOPMENT AND REGULATORY SCIENCE)

    2025

  • SEMINAR: (DRUG DEVELOPMENT AND REGULATORY SCIENCE)

    2025

  • RESEARCH FOR BACHELOR'S THESIS 1

    2025

  • REGULATORY SCIENCE ADVANCED COURSE

    2025

  • PUBLIC HEALTH AND EPIDEMIOLOGY

    2025

display all >>